Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.
Centrally acting angiotensin-converting enzyme inhibitors (CACE-Is) reduce the rate of cognitive decline in patients with dementia, regardless of blood pressure levels at the time of their ...
kidney Risk of mortality in HF patients with reduced kidney function taking ACE inhibitors and ARBs were evaluated. WASHINGTON, DC—According to data presented at the ACC.17 Scientific Session, ...
Blockade of the renin-angiotensin-aldosterone-system with either an angiotensin receptor blocker (ARB) or angiotensin-converting enzyme (ACE) inhibitor provides similar protection from cardiovascular ...
benazepril HCl Lotensin 5mg, 10mg, 20mg, 40mg tabs Adults: If not on diuretic: initially 10mg daily. Usual maintenance: 20−40mg daily in 1 or 2 divided doses; usual max 80mg/day. If on diuretic: ...
Blood pressure management is important for reducing your risk of other conditions, like heart attack or stroke. Guidelines for treating high blood pressure recommend angiotensin-converting enzyme ...
Elderly patients with memory problems who suddenly have visual hallucinations may need to stop taking ACE inhibitors, researchers suggested. In four case studies, the hallucinations experienced by ...
Please provide your email address to receive an email when new articles are posted on . Most physicians are well aware that the most common adverse effects of ACE inhibitors is a dry cough, which can ...
A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...
COPENHAGEN, DENMARK (updated) — Results from a large retrospective study suggest that controlling the activation of the renin-angiotensin system (RAS) with antihypertensive medications reduces the ...
Please provide your email address to receive an email when new articles are posted on . In a review published in the Journal of the American College of Cardiology, four experts stated there is no ...
This drug-utilization study in a prescription database of more than 50,000 patients analyzed compliance, persistence, and switching behavior for ACE inhibitors and ARBs. Although residual confounding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results